Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleAssessing the risk–benefit profile of classical psychedelics: a clinical review of second-wave psychedelic research.AuthorsBender, David; Hellerstein, David J.SubjectsHALLUCINOGENIC drugs; PSILOCYBIN; LSD (Drug); AYAHUASCA; MENTAL depression; ADVERSE health care eventsPublicationPsychopharmacology, 2022, Vol 239, Issue 6, p1907ISSN0033-3158Publication typeArticleDOI10.1007/s00213-021-06049-6